Le SIDA en Afrique subsaharienne (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

HIV-Associated Tuberculosis.

Identifieur interne : 000586 ( PubMed/Curation ); précédent : 000585; suivant : 000587

HIV-Associated Tuberculosis.

Auteurs : Kogieleum Naidoo [Afrique du Sud] ; Kasavan Naidoo ; Nesri Padayatchi ; Quarraisha Abdool Karim

Source :

RBID : pubmed:20871843

Abstract

The intersecting HIV and Tuberculosis epidemics in countries with a high disease burden of both infections pose many challenges and opportunities. For patients infected with HIV in high TB burden countries, the diagnosis of TB, ARV drug choices in treating HIV-TB coinfected patients, when to initiate ARV treatment in relation to TB treatment, managing immune reconstitution, minimising risk of getting infected with TB and/or managing recurrent TB, minimizing airborne transmission, and infection control are key issues. In addition, given the disproportionate burden of HIV in women in these settings, sexual reproductive health issues and particular high mortality rates associated with TB during pregnancy are important. The scaleup and resource allocation to access antiretroviral treatment in these high HIV and TB settings provide a unique opportunity to strengthen both services and impact positively in meeting Millennium Development Goal 6.

DOI: 10.1155/2011/585919
PubMed: 20871843

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:20871843

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">HIV-Associated Tuberculosis.</title>
<author>
<name sortKey="Naidoo, Kogieleum" sort="Naidoo, Kogieleum" uniqKey="Naidoo K" first="Kogieleum" last="Naidoo">Kogieleum Naidoo</name>
<affiliation wicri:level="1">
<nlm:affiliation>CAPRISA Treatment Research Program, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, 4013 Durban, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>CAPRISA Treatment Research Program, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, 4013 Durban</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Naidoo, Kasavan" sort="Naidoo, Kasavan" uniqKey="Naidoo K" first="Kasavan" last="Naidoo">Kasavan Naidoo</name>
</author>
<author>
<name sortKey="Padayatchi, Nesri" sort="Padayatchi, Nesri" uniqKey="Padayatchi N" first="Nesri" last="Padayatchi">Nesri Padayatchi</name>
</author>
<author>
<name sortKey="Abdool Karim, Quarraisha" sort="Abdool Karim, Quarraisha" uniqKey="Abdool Karim Q" first="Quarraisha" last="Abdool Karim">Quarraisha Abdool Karim</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:20871843</idno>
<idno type="pmid">20871843</idno>
<idno type="doi">10.1155/2011/585919</idno>
<idno type="wicri:Area/PubMed/Corpus">000586</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000586</idno>
<idno type="wicri:Area/PubMed/Curation">000586</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000586</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">HIV-Associated Tuberculosis.</title>
<author>
<name sortKey="Naidoo, Kogieleum" sort="Naidoo, Kogieleum" uniqKey="Naidoo K" first="Kogieleum" last="Naidoo">Kogieleum Naidoo</name>
<affiliation wicri:level="1">
<nlm:affiliation>CAPRISA Treatment Research Program, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, 4013 Durban, South Africa.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>CAPRISA Treatment Research Program, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, 4013 Durban</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Naidoo, Kasavan" sort="Naidoo, Kasavan" uniqKey="Naidoo K" first="Kasavan" last="Naidoo">Kasavan Naidoo</name>
</author>
<author>
<name sortKey="Padayatchi, Nesri" sort="Padayatchi, Nesri" uniqKey="Padayatchi N" first="Nesri" last="Padayatchi">Nesri Padayatchi</name>
</author>
<author>
<name sortKey="Abdool Karim, Quarraisha" sort="Abdool Karim, Quarraisha" uniqKey="Abdool Karim Q" first="Quarraisha" last="Abdool Karim">Quarraisha Abdool Karim</name>
</author>
</analytic>
<series>
<title level="j">Clinical & developmental immunology</title>
<idno type="eISSN">1740-2530</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The intersecting HIV and Tuberculosis epidemics in countries with a high disease burden of both infections pose many challenges and opportunities. For patients infected with HIV in high TB burden countries, the diagnosis of TB, ARV drug choices in treating HIV-TB coinfected patients, when to initiate ARV treatment in relation to TB treatment, managing immune reconstitution, minimising risk of getting infected with TB and/or managing recurrent TB, minimizing airborne transmission, and infection control are key issues. In addition, given the disproportionate burden of HIV in women in these settings, sexual reproductive health issues and particular high mortality rates associated with TB during pregnancy are important. The scaleup and resource allocation to access antiretroviral treatment in these high HIV and TB settings provide a unique opportunity to strengthen both services and impact positively in meeting Millennium Development Goal 6.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">20871843</PMID>
<DateCreated>
<Year>2010</Year>
<Month>09</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2012</Year>
<Month>09</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>05</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1740-2530</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>2011</Volume>
<PubDate>
<Year>2011</Year>
</PubDate>
</JournalIssue>
<Title>Clinical & developmental immunology</Title>
<ISOAbbreviation>Clin. Dev. Immunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>HIV-Associated Tuberculosis.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1155/2011/585919</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">585919</ELocationID>
<Abstract>
<AbstractText>The intersecting HIV and Tuberculosis epidemics in countries with a high disease burden of both infections pose many challenges and opportunities. For patients infected with HIV in high TB burden countries, the diagnosis of TB, ARV drug choices in treating HIV-TB coinfected patients, when to initiate ARV treatment in relation to TB treatment, managing immune reconstitution, minimising risk of getting infected with TB and/or managing recurrent TB, minimizing airborne transmission, and infection control are key issues. In addition, given the disproportionate burden of HIV in women in these settings, sexual reproductive health issues and particular high mortality rates associated with TB during pregnancy are important. The scaleup and resource allocation to access antiretroviral treatment in these high HIV and TB settings provide a unique opportunity to strengthen both services and impact positively in meeting Millennium Development Goal 6.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Naidoo</LastName>
<ForeName>Kogieleum</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>CAPRISA Treatment Research Program, Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, 4013 Durban, South Africa.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Naidoo</LastName>
<ForeName>Kasavan</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Padayatchi</LastName>
<ForeName>Nesri</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Abdool Karim</LastName>
<ForeName>Quarraisha</ForeName>
<Initials>Q</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>09</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Egypt</Country>
<MedlineTA>Clin Dev Immunol</MedlineTA>
<NlmUniqueID>101183692</NlmUniqueID>
<ISSNLinking>1740-2522</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2001 Sep 28;15(14):1857-63</RefSource>
<PMID Version="1">11579249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Tuberc Lung Dis. 2009 Jul;13(7):855-61</RefSource>
<PMID Version="1">19555535</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2009 Mar;9(3):197-202</RefSource>
<PMID Version="1">19246023</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Infect Control. 2005 Mar;33(2):114-21</RefSource>
<PMID Version="1">15761412</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Tuberc Lung Dis. 1999 Apr;3(4):330-6</RefSource>
<PMID Version="1">10206504</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2007 Aug 15;196 Suppl 1:S35-45</RefSource>
<PMID Version="1">17726832</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2010 Jan 1;181(1):80-6</RefSource>
<PMID Version="1">19833824</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2007 Aug 15;196 Suppl 1:S63-75</RefSource>
<PMID Version="1">17624828</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000171</RefSource>
<PMID Version="1">20091503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Wkly Epidemiol Rec. 1999 Nov 19;74(46):385-98</RefSource>
<PMID Version="1">10611855</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hosp Infect. 2007 May;66(1):1-5</RefSource>
<PMID Version="1">17350724</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2006 Oct 12;355(15):1539-50</RefSource>
<PMID Version="1">17035648</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 1995 Mar 23;332(12):779-84</RefSource>
<PMID Version="1">7862181</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2003 Jul 1;37(1):101-12</RefSource>
<PMID Version="1">12830415</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2010 Mar 24;5(3):e9848</RefSource>
<PMID Version="1">20352098</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2001 Nov 17;358(9294):1687-93</RefSource>
<PMID Version="1">11728545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2007 Feb;4(2):e68</RefSource>
<PMID Version="1">17326709</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2005 Nov 18;19(17 ):2049-50</RefSource>
<PMID Version="1">16260919</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 1993 Dec;7(12):1569-79</RefSource>
<PMID Version="1">7904450</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2007 Jan 30;21(3):381-2</RefSource>
<PMID Version="1">17255750</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Occup Environ Hyg. 2005 May;2(5):285-92</RefSource>
<PMID Version="1">15848970</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 1998 Jul;158(1):157-61</RefSource>
<PMID Version="1">9655723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2004 Aug 20;18(12):1615-27</RefSource>
<PMID Version="1">15280772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr;9(2):104-8</RefSource>
<PMID Version="1">20160249</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 1997 Jun;11(7):919-25</RefSource>
<PMID Version="1">9189218</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Pediatr. 2008 Jan 11;8:1</RefSource>
<PMID Version="1">18186944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cochrane Database Syst Rev. 2004;(1):CD000171</RefSource>
<PMID Version="1">14973947</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2005 Jul 22;19(11):1201-6</RefSource>
<PMID Version="1">15990574</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Infect Dis. 2010 Feb 26;10:41</RefSource>
<PMID Version="1">20187922</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Radiology. 1994 Oct;193(1):115-9</RefSource>
<PMID Version="1">7916467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Med. 2009 Mar 17;6(3):e43</RefSource>
<PMID Version="1">19296717</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2005 Jul 22;19(11):1113-24</RefSource>
<PMID Version="1">15990564</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2007 Jan 30;21(3):335-41</RefSource>
<PMID Version="1">17255740</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2010 May 22;375(9728):1798-807</RefSource>
<PMID Version="1">20488525</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2010 Apr;10(4):251-61</RefSource>
<PMID Version="1">20334848</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2000 Oct 28;356(9240):1470-4</RefSource>
<PMID Version="1">11081529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Trop Pediatr. 1993 Aug;39(4):219-23</RefSource>
<PMID Version="1">8411315</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMJ. 2007 Jan 20;334(7585):136</RefSource>
<PMID Version="1">17085459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1574-6</RefSource>
<PMID Version="1">15577411</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2005 Jun;5(6):361-73</RefSource>
<PMID Version="1">15919622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2009 Mar 13;23(5):631-6</RefSource>
<PMID Version="1">19525621</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2007 Jul 11;21(11):1441-8</RefSource>
<PMID Version="1">17589190</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107</RefSource>
<PMID Version="1">17624830</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bull World Health Organ. 1982;60(4):555-64</RefSource>
<PMID Version="1">6754120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2004 Dec 1;39(11):1709-12</RefSource>
<PMID Version="1">15578375</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2007 Aug 15;196 Suppl 1:S52-62</RefSource>
<PMID Version="1">17624827</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 1991;4(8):770-6</RefSource>
<PMID Version="1">1677419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Tuberc Lung Dis. 2000 May;4(5):455-62</RefSource>
<PMID Version="1">10815740</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Tuberc Lung Dis. 2009 Aug;13(8):927-35</RefSource>
<PMID Version="1">19723371</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Tuberc Lung Dis. 2008 Apr;12 (4):397-403</RefSource>
<PMID Version="1">18371265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):865-72</RefSource>
<PMID Version="1">10988097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Acquir Immune Defic Syndr. 2010 May 1;54(1):71-7</RefSource>
<PMID Version="1">19934764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Med Int Health. 2005 Aug;10(8):734-42</RefSource>
<PMID Version="1">16045459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2010 Apr 10;375(9722):1278-86</RefSource>
<PMID Version="1">20347483</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2009 Mar;9(3):173-84</RefSource>
<PMID Version="1">19246021</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Infect Control. 2005 Mar;33(2):88-96</RefSource>
<PMID Version="1">15761408</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Tuberc Lung Dis. 2009 Oct;13(10):1253-9</RefSource>
<PMID Version="1">19793430</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS Rev. 2003 Apr-Jun;5(2):67-79</RefSource>
<PMID Version="1">12876896</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Infect Dis. 2007 Aug 15;196 Suppl 1:S108-13</RefSource>
<PMID Version="1">17624819</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Can J Infect Dis Med Microbiol. 2008 Mar;19(2):169-72</RefSource>
<PMID Version="1">19352448</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Microbiol. 2010 Jan;48(1):229-37</RefSource>
<PMID Version="1">19864480</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Drugs. 2008;68(2):191-208</RefSource>
<PMID Version="1">18197725</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Gynaecol Obstet. 2010 Mar;108(3):181-3</RefSource>
<PMID Version="1">20070964</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2010 Feb 25;362(8):697-706</RefSource>
<PMID Version="1">20181971</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>S Afr Med J. 2007 May;97(5):363-6</RefSource>
<PMID Version="1">17599219</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2010 May 15;50 Suppl 3:S238-44</RefSource>
<PMID Version="1">20397954</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 2001 Nov 9;15(16):2129-35</RefSource>
<PMID Version="1">11684932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>AIDS. 1998 Dec 24;12(18):2447-57</RefSource>
<PMID Version="1">9875583</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 1997 Aug;25(2):242-6</RefSource>
<PMID Version="1">9332519</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Infect Dis. 2008 Aug;8(8):516-23</RefSource>
<PMID Version="1">18652998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 1995 Jul 24;155(14):1537-42</RefSource>
<PMID Version="1">7605156</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC2943082</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2010</Year>
<Month>06</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2010</Year>
<Month>07</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2010</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">20871843</ArticleId>
<ArticleId IdType="doi">10.1155/2011/585919</ArticleId>
<ArticleId IdType="pmc">PMC2943082</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000586 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000586 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:20871843
   |texte=   HIV-Associated Tuberculosis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:20871843" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaSubSaharaV1 

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024